Artificial Pancreas Device System Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

How Will the Artificial Pancreas Device System Market Grow, and What Is the Projected Market Size?
The market for artificial pancreas device systems has experienced a significant expansion in recent years. The market value is forecasted to surge from $1.81 billion in 2024 to $2.07 billion in 2025, with a compound annual growth rate (CAGR) of 14.1%. The historic market growth can be explained by factors such as escalating investments, increased government efforts in clinical investigations, a rising demand for automated glycemic control systems, aggressive research and development undertakings by industry participants, and a growing older population.

In the coming years, the market for artificial pancreas device systems is projected to experience a swift expansion. The market value is anticipated to surge to $3.48 billion by 2029, with an impressive compound annual growth rate (CAGR) of 13.9%. Factors contributing to this growth throughout the forecast period encompass an escalating prevalence of diabetes, a higher incidence of pancreatic cancer, an increase in instances of diabetes and obesity, a rising demand for minimally invasive (MI) drug delivery systems, along with advances in diabetes management technology. The forecast period is also expected to witness notable trends like tech-based innovations, amplified research and development endeavors, more product approvals, collaborative ventures and partnerships, coupled with an upswing in tele-consultancy activities for follow-ups.

What Is Driving the Growth Trajectory of the Artificial Pancreas Device System Market?
The growth of the artificial pancreas device system market is projected to be driven by the rising occurrence of pancreatic cancer. This type of cancer is a deadly tumour that begins in the pancreas, a gland positioned behind the stomach. It is influenced by elements such as lifestyle, genetic, medical, and environmental factors, along with genetic mutations which can cause hereditary pancreatitis, resulting in chronic inflammation of the pancreas. The primary function of an artificial pancreas device system (APDS) is to assist those with diabetes in managing their blood sugar levels. It does this by continuously observing glucose and dispensing the required insulin dosage. For example, Cancer Australia, a government institution, projected in March 2024 that there were 4,506 new pancreatic cancer diagnoses in 2023, which marked an increase from the 3,751 cases identified in the previous five years. Consequently, the escalating incidence of pancreatic cancer is fuelling the expansion of the artificial pancreas device system market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp

Who Are the Major Industry Players Fueling Artificial Pancreas Device System Market Expansion?
Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd

Which Key Developments Are Influencing the Artificial Pancreas Device System Market?
Companies that play a significant role in the artificial pancreas device system market are focusing on the creation of automatic insulin dispensing technologies. These are designed to improve the management of diabetes by autonomously checking blood sugar levels and administering the appropriate insulin doses. The objective is to emulate a functioning pancreas, thereby lessening the need for individuals living with diabetes to manually oversee their blood sugar levels and insulin needs. For example, in May 2023, Beta Bionics, an American company specializing in medical equipment production, attained FDA 510(k) clearance for their iLet Insulin-Only Bionic Pancreas System. This autonomous insulin delivery apparatus emulates an artificial pancreas' function to independently ascertain and dispense insulin doses to regulate blood glucose levels. Its enclosed loop system, which is linked to a continuous glucose monitor (CGM), adjusts insulin administration based on the measured glucose levels of the user. The system only needs the user's body mass and a meal sizing estimate to adjust insulin dispensation autonomously.

How Is the Segmentation of the Artificial Pancreas Device System Market Defined?
The artificial pancreas device system market covered in this report is segmented -

1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid
3) By End-User: Hospitals, Medical Centers, Other End-Users

Subsegments:
1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems
2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems
3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/artificial-pancreas-device-system-global-market-report

What Is the Leading Region in the Artificial Pancreas Device System Market?
North America was the largest region in the artificial pancreas device system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Artificial Pancreas Device System Global Market Report?

- Market Size Analysis: Analyze the Artificial Pancreas Device System Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Artificial Pancreas Device System Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Artificial Pancreas Device System Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Artificial Pancreas Device System Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18229

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.